Literature DB >> 16095496

Gene expression profiling in murine obliterative airway disease.

Jeffrey D Lande1, Stacy L Dalheimer, Daniel L Mueller, Marshall I Hertz, Richard A King.   

Abstract

Lung and heart-lung transplantation are effective treatments for many diseases unresponsive to other therapy. However, long-term survival of recipients is limited by the development of obliterative bronchiolitis (OB). In this study, microarray analysis of a heterotopic mouse model of obliterative airway disease (OAD) was used to test the hypothesis that the expression and patterns of genes will correlate with specific changes in tracheal tissue developing a response to allotransplantation and the infiltrating cells manifesting these changes. Expression profiles observed were in accordance with the current paradigm of a predictable sequence of events, beginning with airway injury; an innate immune response followed by an adaptive immune response, including both cell-mediated and humoral components; and eventual loss of airway epithelial cells. These observations confirm and expand the list of genes and molecular processes that can be studied as potential surrogate markers or targets for intervention of OB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16095496     DOI: 10.1111/j.1600-6143.2005.01026.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  3 in total

Review 1.  Novel insights into lung transplant rejection by microarray analysis.

Authors:  Jeffrey D Lande; Jagadish Patil; Na Li; Todd R Berryman; Richard A King; Marshall I Hertz
Journal:  Proc Am Thorac Soc       Date:  2007-01

2.  Activation of eosinophil CCR3 signaling and eotaxin using a bioinformatics analysis of a mouse model of obliterative airway disease.

Authors:  Amrita Dosanjh
Journal:  J Interferon Cytokine Res       Date:  2014-04-04       Impact factor: 2.607

3.  Activation of counter-regulatory mechanisms in a rat renal acute rejection model.

Authors:  Bayram Edemir; Sunil M Kurian; Martin Eisenacher; Detlef Lang; Carsten Müller-Tidow; Gert Gabriëls; Daniel R Salomon; Eberhard Schlatter
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.